Correlation Between Intact Financial and Medexus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Intact Financial and Medexus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intact Financial and Medexus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Intact Financial and Medexus Pharmaceuticals, you can compare the effects of market volatilities on Intact Financial and Medexus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intact Financial with a short position of Medexus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intact Financial and Medexus Pharmaceuticals.

Diversification Opportunities for Intact Financial and Medexus Pharmaceuticals

0.57

Correlation Coefficient

Intact Financial  Medexus Pharmaceuticals

Very weak diversification

The 3 months correlation between Intact and Medexus is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Intact Financial and Medexus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medexus Pharmaceuticals and Intact Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intact Financial are associated (or correlated) with Medexus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medexus Pharmaceuticals has no effect on the direction of Intact Financial i.e., Intact Financial and Medexus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Intact Financial and Medexus Pharmaceuticals

Assuming the 90 days trading horizon Intact Financial is expected to under-perform the Medexus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Intact Financial is 2.56 times less risky than Medexus Pharmaceuticals. The stock trades about -0.1 of its potential returns per unit of risk. The Medexus Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  294.00  in Medexus Pharmaceuticals on May 25, 2025 and sell it today you would lose (7.00) from holding Medexus Pharmaceuticals or give up 2.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Intact Financial  vs.  Medexus Pharmaceuticals

Intact Financial

Risk-Adjusted Performance

Weakest

Over the last 90 days Intact Financial has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Medexus Pharmaceuticals

Risk-Adjusted Performance

Weakest

Over the last 90 days Medexus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Medexus Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Intact Financial and Medexus Pharmaceuticals

The main advantage of trading using opposite Intact Financial and Medexus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intact Financial position performs unexpectedly, Medexus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medexus Pharmaceuticals will offset losses from the drop in Medexus Pharmaceuticals' long position.

The idea behind Intact Financial and Medexus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.